The Palico Private Equity Fund Marketplace
New Leaf Venture Partners is a private equity general partner firm located in United States.
PE-backed Crispr Therapeutics, a Switzerland-based gene-editing company, has priced its 4m common shares at $14 per share.
VC-backed Truveris, a provider of prescription drug ecosystem solutions, has named Faisal Mushtaq as CEO.
Crispr Therapeutics, a Switzerland-based gene-editing company, raised an additional $38m in the second close of its Series B financing.
Read more news concerning New Leaf Venture Partners
A sampling of New Leaf Venture Partners portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?